It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Multiple Sclerosis (MS) is an inflammatory, chronic, autoimmune, and demyelinating disease of the central nervous system. MS is a heterogeneous disease with three main clinical forms, affecting the progression and therefore the treatment of the disease. Thus, finding key genes and microRNAs (miRNA) associated with MS stages and analyzing their interactions is important to better understand the molecular mechanism underlying the occurrence and the evolution of MS. Based on publicly available datasets of mRNA and miRNA expression profiles, differentially expressed genes (DEGs) and differentially expressed miRNAs (DEMs) between patients with different stages of MS and healthy controls and between relapsing and remitting phases of RRMS were determined using Deseq2 and GEO2R tools. We then analyzed miRNA-mRNA regulatory interactions and gene ontology for the DEGs. Based on miRNA-mRNA regulatory interactions, we identified potential biomarkers of RRMS, 13 upregulated miRNA regulators of 30 downregulated genes and 17 downregulated miRNA regulators of 32 upregulated genes. We also identified 9 downregulated miRNA regulators of 12 upregulated genes as potential biomarkers of SPMS. Our study findings highlight some key protein-coding genes and miRNAs that are involved in the occurrence and evolution of MS.
Competing Interest Statement
The authors have declared no competing interest.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer